OCT 07, 2021 8:30 AM PDT

Computational Crystal Ball Predicts Which COVID Variants Are More Dangerous

WRITTEN BY: Tara Fernandes

Viruses are nature’s shapeshifters—their genomes are in a constant state of flux as they divide in their hosts. Over time, they gradually acquire a library of errors that eventually change the way the virus behaves.

This evolutionary phenomenon has led to the emergence of SARS-CoV-2 variants such as Delta; a COVID variant thought to be more than twice as contagious as previous iterations of the coronavirus.

Given that the virus always seems to be one step ahead of efforts to control the pandemic, researchers have been seeking ways of predicting exactly how SARS-CoV-2 is changing over time and what that means from an epidemiological standpoint. Such platforms would buy us time, signaling the potential emergence of a potentially more dangerous variant before it sweeps through and devastates communities.

To this end, scientists at Penn State have made a giant leap forward, creating the first computational framework for predicting genetic changes in the coronavirus’ spike protein. The virus uses this protein as a molecular key to gain entry into human cells via their ACE2 receptors.

The vast majority of circulating variants possess mutations in the spike protein’s receptor binding domain (RBD). These amino acid changes boost the infectivity of the virus, allowing SARS-CoV-2 to enter and infect human cells faster and more easily, making the virus more transmissible. These accumulated changes in the RBD may also help variants evade the immune systems of vaccinated individuals or those who have recovered from COVID-19.

In their study, the researchers developed a two-step computational framework that models changes occurring in the RBD and links these mutations to the ability of the virus to bind to human ACE2 receptors.

“The binding strength between RBD and ACE2 directly affects infection dynamics and potentially disease progression,” explained the lead investigator of the study, Suresh Kuchipudi. 

“The ability to reliably predict the effects of virus amino-acid changes in the ability of its RBD to interact more strongly with the ACE2 receptor can help in assessing public health implications and the potential for spillover and adaptation into humans and other animals.”

Kuchipudi and colleagues leveraged a technique known as Molecular Mechanics-Generalized Born Surface Area (MM-GBSA) analysis, which measures how strongly the virus RBD binds to ACE2. Powered by binding affinity data of existing variants, their new framework uses a deep-learning algorithm to help predict the effects of amino acid changes in the RBD.

The team found that they could predict with over 80 percent accuracy whether or not RBD amino acid mutations improved or worsened the virus’ ability to latch on to ACE-2.

This new framework would empower public health officials with a tool to assess the infectivity of currently circulating and emerging SARS-CoV-2 variants in terms of their infectivity. If a new strain is predicted to have a greater binding affinity to ACE2, countermeasures to protect the public can rapidly be deployed to save lives. 



 

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
OCT 12, 2022
Cannabis Sciences
Cannabis Use for Menopausal Symptoms
OCT 12, 2022
Cannabis Use for Menopausal Symptoms
A study published in Menopause found that women are increasingly using medical cannabis to alleviate menopause-related s ...
OCT 08, 2022
Coronavirus
Carriers of Certain APOE Variants are More Vulnerable to Severe COVID-19
OCT 08, 2022
Carriers of Certain APOE Variants are More Vulnerable to Severe COVID-19
Researchers have long known that certain things are risk factors for severe cases of COVID-19, such as old age or obesit ...
OCT 11, 2022
Cardiology
Refined Grain Consumption Increases Heart Disease Risk
OCT 11, 2022
Refined Grain Consumption Increases Heart Disease Risk
Refined grains like white bread have been linked to the development of premature coronary artery disease.
NOV 02, 2022
Health & Medicine
[White Paper] Optimizing Sequencing Costs in Metagenomics. How to Reduce Costs of Pathogen Detection with PaRTI-Seq™
NOV 02, 2022
[White Paper] Optimizing Sequencing Costs in Metagenomics. How to Reduce Costs of Pathogen Detection with PaRTI-Seq™
Optimizing sequencing costs in metagenomics: How to reduce costs of pathogen detection in with PaRTI-Seq™ Pathogen ...
NOV 17, 2022
Cancer
Anti-Aging Supplement Linked to Aggressive Breast Cancer
NOV 17, 2022
Anti-Aging Supplement Linked to Aggressive Breast Cancer
Vitamin B3, also known as niacin, is a generic name for a group of biochemical compounds, including nicotinamide ribosid ...
NOV 21, 2022
Immunology
Unusual, Ultrapotent Antibody Against Zika is Discovered
NOV 21, 2022
Unusual, Ultrapotent Antibody Against Zika is Discovered
Zika virus is transmitted by the Aedes aegypti mosquito and can cause a mild illness in otherwise healthy adults. But wh ...
Loading Comments...